[Human T-cell lymphotrophic virus type I and T-cell lymphoma]. 1996

A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
Onkologisk avdeling Det Norske Radiumhospital, Oslo.

Human T-cell lymphotropic virus type I is an oncogenic retrovirus, endemic in Southwestern Japan, the Caribbean, some parts of Africa and Central and South America. The virus is etiologically associated with adult T-cell leukemia/lymphoma and a myelopathy called tropical spastic paraparesis or HTLV-I associated myelopathy. Transmission of the virus is almost identical to that of HIV. The latency period before onset of clinical symptoms can last from a few years (tropical spastic paraparesis) up to several decades (adult T-cell leukemia/lymphoma). Four different clinicopathological subtypes of the T-cell neoplasia are known, and in this article we describe two patients with the subtype lymphoma.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D015459 Leukemia-Lymphoma, Adult T-Cell Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. ATLL,HTLV I Associated T Cell Leukemia Lymphoma,HTLV-Associated Leukemia-Lymphoma,HTLV-I-Associated T-Cell Leukemia-Lymphoma,Human T Lymphotropic Virus Associated Leukemia Lymphoma,Human T Lymphotropic Virus-Associated Leukemia-Lymphoma,Human T-Cell Leukemia-Lymphoma,Leukemia Lymphoma, Adult T Cell,Leukemia Lymphoma, T Cell, Acute, HTLV I Associated,Leukemia, Adult T-Cell,Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated,T Cell Leukemia Lymphoma, HTLV I Associated,T Cell Leukemia, Adult,T-Cell Leukemia, Adult,T-Cell Leukemia-Lymphoma, Adult,T-Cell Leukemia-Lymphoma, HTLV-I-Associated,Adult T-Cell Leukemia,Adult T-Cell Leukemia-Lymphoma,Adult T-Cell Leukemia-Lymphomas,Adult T-Cell Leukemias,HTLV Associated Leukemia Lymphoma,HTLV-Associated Leukemia-Lymphomas,HTLV-I-Associated T-Cell Leukemia-Lymphomas,Human T Cell Leukemia Lymphoma,Human T-Cell Leukemia-Lymphomas,Leukemia, Adult T Cell,Leukemia-Lymphoma, HTLV-Associated,Leukemia-Lymphoma, HTLV-I-Associated T-Cell,Leukemia-Lymphoma, Human T-Cell,Leukemia-Lymphomas, Adult T-Cell,Leukemia-Lymphomas, HTLV-Associated,Leukemia-Lymphomas, HTLV-I-Associated T-Cell,Leukemia-Lymphomas, Human T-Cell,Leukemias, Adult T-Cell,T Cell Leukemia Lymphoma, Adult,T-Cell Leukemia-Lymphoma, Human,T-Cell Leukemia-Lymphomas, Adult,T-Cell Leukemia-Lymphomas, HTLV-I-Associated,T-Cell Leukemia-Lymphomas, Human,T-Cell Leukemias, Adult
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015482 HTLV-II Antibodies Antibodies reactive with the HTLV-II ANTIGENS. Human T-Cell Leukemia Virus II Antibodies,Human T-Lymphotropic Virus II Antibodies,Leukemia-Lymphoma Virus II Antibodies, Human T-Cell,T-Cell Leukemia Virus II Antibodies, Human,HTLV II Antibodies,Human T Cell Leukemia Virus II Antibodies,Human T Lymphotropic Virus II Antibodies,Leukemia Lymphoma Virus II Antibodies, Human T Cell,T Cell Leukemia Virus II Antibodies, Human,Antibodies, HTLV II,Antibodies, HTLV-II,II Antibodies, HTLV

Related Publications

A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
January 1994, The Journal of emergency medicine,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
June 1990, Annals of neurology,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
May 1999, British journal of haematology,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
August 1996, Journal of medical primatology,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
March 1998, Current opinion in pulmonary medicine,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
March 2001, American journal of ophthalmology,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
January 2003, Journal of long-term effects of medical implants,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
September 1996, The Journal of investigative dermatology,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
November 1996, Archives of dermatology,
A Loraas, and K Lote, and H H Samdal, and K Beiske, and R Langholm
July 2003, Clinical and experimental dermatology,
Copied contents to your clipboard!